腫瘍病理鑑別診断アトラス　骨腫瘍

出版社： 文光堂
著者：
発行日： 2016-05-03
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784830622496
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2016-05-03 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
発送目安：8～14営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

骨腫瘍の中でも高頻度のものを中心に，最新の診断基準に沿って，典型的な組織像を供覧し解説する．バリエーションの多い骨肉腫と軟骨肉腫では，亜型により全く悪性度が異なることも考慮し，多くの紙面を割いた．また，病理診断でよく遭遇する組織学的所見を呈する腫瘍[骨形成性腫瘍，軟骨形成性腫瘍，巨細胞の多く出現する腫瘍，小円形細胞腫瘍および上皮様の形態を呈する腫瘍]を系統的に解説．骨腫瘍の診断・治療を行う多くの医師必携の書．

目次

  • 腫瘍病理鑑別診断アトラス　骨腫瘍

    ―目次―

    第１部　検鏡前の確認事項
    I．骨腫瘍のWHO分類：分類の変遷と最新の分類の問題点
    　１．主な変更点
    　２．問題点
    II．骨腫瘍の頻度，年齢，発生部位
    　１．骨腫瘍の発生頻度
    　２．骨腫瘍の発生年齢
    　３．骨腫瘍の発生部位
    III．病理標本の取扱い方
    　１．術中迅速診断
    　２．生検検体
    　３．手術検体

    第２部　組織型と診断の実際
    I．軟骨形成性腫瘍
    　１．良性軟骨形成性腫瘍
    　２．中間性軟骨形成性腫瘍：軟骨芽細胞腫と軟骨粘液線維腫
    　３．通常型および二次性軟骨肉腫
    　４．特殊型軟骨肉腫
    II．骨形成性腫瘍
    　１．良性・中間性骨形成性腫瘍
    　２．通常型骨肉腫
    　３．特殊型骨肉腫
    　４．表在性骨肉腫
    III．線維性および線維組織球性腫瘍
    　１．類腱線維腫と非骨化性線維腫/骨幹端線維性欠損/
    　　　良性線維性組織球腫
    IV．富破骨細胞性巨細胞腫瘍
    　１．指趾骨巨細胞性病変/巨細胞修復性肉芽腫
    　２．骨巨細胞腫
    V．脊索性腫瘍
    　１．良性脊索細胞腫と脊索腫
    VI．血管性腫瘍
    　１．血管腫（良性）および類上皮血管腫（中間性）
    　２．類上皮血管内皮腫および血管肉腫
    VII．性状が不明確な腫瘍
    　１．単発性骨?腫
    　２．線維性異形成
    　３．骨線維性異形成
    　４．動脈瘤様骨?腫
    　５．Langerhans細胞組織球症
    VIII．関節腫瘍
    　１．色素性絨毛結節性滑膜炎
    　２．滑膜軟骨腫症
    　３．滑膜脂肪腫
    IX．その他の腫瘍
    　１．Ewing肉腫
    　２．アダマンチノーマ
    　３．骨未分化高悪性度多形肉腫

    第３部　鑑別ポイント
    I．骨肉腫との鑑別を要する骨形成性腫瘍
    　１．骨肉腫の亜型と特徴
    　２．髄内骨肉腫と表在性骨肉腫の関係
    　３．組織所見からみた骨肉腫の鑑別診断
    II．軟骨肉腫と鑑別を要する軟骨形成性腫瘍
    　１．軟骨芽細胞型骨肉腫
    　２．内軟骨腫
    　３．軟骨芽細胞腫
    　４．軟骨粘液線維腫
    　５．線維軟骨性異形成
    　６．滑膜軟骨腫症
    　７．ピロリン酸カルシウム結晶沈着症
    III．巨細胞の出現する腫瘍の鑑別
    　１．臨床的事項
    　２．組織学的診断時の注意事項
    　３．鑑別を要するOCGCの出現する各疾患の組織学的特徴
    IV．骨小円形細胞腫瘍の鑑別診断
    　１．Ewing肉腫とEwing様肉腫
    　２．小細胞骨肉腫とEwing肉腫
    　３．骨リンパ腫
    　４．形質細胞腫瘍
    　５．間葉性軟骨肉腫と骨肉腫
    　６．癌腫の転移
    　７．そのほかの鑑別
    V．転移性骨腫瘍と上皮様骨腫瘍の鑑別
    　１．定義・概念
    　２．鑑別の要点
    　３．上皮様骨腫瘍の鑑別診断の実際

    第４部　臨床との連携
    I．骨腫瘍の外科治療
    　１．骨腫瘍に対する標準的外科治療
    　２．手術後の再建法
    II．悪性骨腫瘍の薬物療法および放射線療法
    　１．病期分類
    　２．薬物療法
    　３．放射線治療
    　４．医師主導臨床試験および治験
    III．免疫染色と遺伝子診断
    　１．骨形成性腫瘍
    　２．軟骨形成性腫瘍
    　３．小円形細胞腫瘍
    　４．富破骨細胞性巨細胞腫瘍
    　５．その他
    IV．骨肉腫の組織学的効果判定と切除縁評価
    　１．骨肉腫の組織学的効果判定
    　２．切除縁評価
    V．病理診断報告書の記載
    　１．病理診断報告書の構成
    　２．病理診断
    　３．病理所見（コメント）

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 検鏡前の確認事項

P.4 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
3) Lichtenstein K : Classification of primary tumors of bone. Cancer 4 : 335-341, 1951
 
4) Fletcher CDM, Unni KK, Mertens F (eds) : WHO Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, 3rd ed, IARC Press, Lyon, 2002
 
5) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2016, pp181-196
 
P.9 掲載の参考文献
1) 日本整形外科学会骨軟部腫瘍委員会 : 平成25年度全国骨腫瘍登録一覧表, 国立がん研究センター, 2013, pp24-31
 
2) Grimer RJ, Hogendoorn PCW, Vanel D : Tumours of bone : Introduction. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp244-247
 
3) Unni KK, Inwards CY, Bridge JA, et al : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints, AFIP, Washington DC, 2005, pp1-10
 
4) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2015, pp1-30
 
5) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp12-18
 
6) 森岡秀夫 (編) : 概論 骨・軟部腫瘍診療のポイント. 整形外科専門医になるための診療スタンダード-4 骨・軟部腫瘍および骨系統・代謝性疾患, 羊土社, 2009, pp12-42
 
P.12 掲載の参考文献
1) Unni KK, Inwards CY, Bridge JA : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints, AFIP, Washington DC, 2005
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012
 
3) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2015
 
4) 福永真治 : 骨・軟部腫瘍. 病理と臨床 31 (臨増) : 352-359, 2013
 
5) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 

第2部 組織型と診断の実際

P.22 掲載の参考文献
1) Bovee JVMG, Heymann D, Wuyts W : Osteochondroma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp250-251
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp137-146
 
3) Endo M, Hasegawa T, Tashiro T, et al : Bizarre parosteal osteochondromatous proliferation with a t (1 ; 17) translocation. Virchows Arch 447 : 99-102, 2005
 
4) Feely MG, Boehm AK, Bridge RS, et al : Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma. Cancer Genet Cytogenet 137 : 102-107, 2002
PubMed
5) Jones KB, Piombo V, Searby C, et al : A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci U S A 107 : 2054-2059, 2010
PubMed
6) Matsumoto K, Irie F, Mackem S, et al : A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci U S A 107 : 10932-10937, 2010
PubMed
7) Lucas DR, Bridge JA : Chondromas : enchondroma, periosteal chondroma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp252-254
 
8) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp120-128
 
9) Hogendoorn PCW, Bovee JVMG, Nielsen GP : Chondrosarcoma (grade I-III), including primary and secondary variants and periosteal chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp264-268
 
10) Sakai Junior N, Abe KT, Formigli LM, et al : Cytogenetic findings in 14 benign cartilaginous neoplasms. Cancer Genet 204 : 180-186, 2011
PubMed
11) Dahlen A, Mertens F, Rydholm A, et al : Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 16 : 1132-1140, 2003
PubMed
12) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
13) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp128-132
 
P.28 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013, pp240-241, 255-256, 262-263
 
2) Bogdan C : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier, Philadelphia, 2015, pp246, 249-250, 400-438, 457
 
3) Jaffe HL, Lichtenstein L : Benign chondroblastoma of bone : a reinterpretation of the so-called calcifying or chondromatous giant cell tumor. Am J Pathol 18 : 969-991, 1942
PubMed
4) Jaf fe HL, Lichtenstein L : Chondromyxoid fibroma of bone ; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol 45 : 541-551, 1948
 
5) Weiss AP, Dorfman HD : S-100 protein in human cartilage lesions. J Bone Joint Surg Am 68 : 521-526, 1986
PubMed
6) Park HR, Park YK, Jang KT, et al : Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibroma. Oncol Rep 9 : 1087-1091, 2002
PubMed
7) Konishi E, Okubo T, Itoi M, et al : Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol 41 : 208-213, 2010
 
P.38 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) Unni KK, Inwards CY : Dahlin's Bone Tumors : General Aspects and Data on 10,165 Cases, 6th ed, Lippincott Williams & Wilkins, Philadelphia, 2010
 
3) Unni KK, Inwards CY, Bridge JA, et al : Tumors of the bones and joints. in Silverberg SG, Sobin LH (eds) : "AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints", AFIP, Washington DC, 2005
 
4) Bovee JVMG, Hogendoorn PCV, Wunder JS, et al : Cartilage tumours and bone development : molecular pathology and possible therapeutic targets. Nat Rev Cancer 10 : 481-488, 2010
 
5) Verdegaal SH, Bovee JV, Pansuriya TC, et al : Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome : an international multicenter study of 161 patients. Oncologist 16 : 1771-1779, 2011
PubMed
6) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
7) Konishi E, Nakashima Y, Mano M, et al : Primary central chondrosarcoma of long bone, limb girdle and trunk : analysis of 174 cases by numerical scoring on histology. Pathol Int 65 : 468-475, 2015
PubMed
8) Nojima T, Unni KK, MacLeod RA, et al : Periosteal chondroma and periosteal chondrosarcoma. Am J Surg Pathol 9 : 666-677, 1985
 
9) Murphey MD, Flemming DJ, Boyea SR, et al : Enchondroma versus chondrosarcoma in the appendicular skeleton : differentiating features. Radiographics 18 : 1213-1237, Quiz 1244-1245, 1998
 
10) Bernard SA, Murphey MD, Flemming DJ, et al : Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging. Radiology 255 : 857-865, 2010
 
11) Bjornsson J, McLeod RA, Unni KK, et al : Primary chondrosarcoma of long bones and limb girdles. Cancer 83 : 2105-2119, 1998
PubMed
12) Evans HL, Ayala AG, Romsdahl MM : Prognostic factors in chondrosarcoma of bone : a clinicopathologic analysis with emphasis on histologic grading. Cancer 40 : 818-831, 1977
 
13) Angelini A, Guerra G, Mavrogenis AF, et al : Clinical outcome of central conventional chondrosarcoma. J Surg Oncol 106 : 929-937, 2012
PubMed
14) Lee FY, Mankin HJ, Fondren G, et al : Chondrosarcoma of bone : an assessment of outcome. J Bone Joint Surg Am 81 : 326-338, 1999
 
15) Gelderblom H, Hogendoorn PC, Bloem JL, et al : The clinical approach towards chondrosarcoma. Oncologist 13 : 320-329, 2008
 
16) Eefting D, Schrage YM, Geirnaerdt MJ, et al : Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol 33 : 50-57, 2009
PubMed
17) Jones KB, Buckwalter JA, McCarthy EF, et al : Reliability of histopathologic and radiologic grading of cartilaginous tumors. J Bone Joint Surg Am 89 : 2113-2123, 2007
 
18) Mirra JM, Gold R, Downs J, et al : A few histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop Relat Res 201 : 214-237, 1985
 
19) Geirnaerdt MJA, Hermans J, Bloem JL, et al : Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. Am J Roentgenol 169 : 1097-1104, 1997
 
20) Jaffe HL : Tumors and Tumorous Conditions of the Bones and Joints, Lea and Febiger, Philadelphia, 1958
 
21) Dahlin DC, Salvador AH : Chondrosarcomas of bones of the hands and feet-a study of 30 cases. Cancer 34 : 755-760, 1974
 
22) Dahlin DC, Henderson ED : Chondrosarcoma, a surgical and pathological problem ; review of 212 cases. J Bone Joint Surg Am 38A : 1025-1038, 1956
 
23) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
24) Amary MF, Damato S, Halai D, et al : Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 43 : 1262-1265, 2011
PubMed
25) Tarpey PS, Behjati S, Cooke SL, et al : Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet 45 : 923-926, 2013
PubMed
26) Tiet TD, Hopyan S, Nadesan P, et al : Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol 168 : 321-330, 2006
PubMed
27) Bridge JA, Nelson M, Orndal C, et al : Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer 82 : 1657-1663, 1998
PubMed
28) Hameetman L, Szuhai K, Yavas A, et al : The role of EXT1 in nonhereditary osteochondroma : identification of homozygous deletions. J Natl Cancer Inst 99 : 396-406, 2007
PubMed
29) de Andrea CE, Reijnders CM, Kroon HM, et al : Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT. Oncogene 31 : 1095-1104, 2012
PubMed
P.50 掲載の参考文献
1) Inwards C, Hogendoorn PCW : Dedifferentiated chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", IARC Press, Lyon, 2013, pp269-270
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp181-186
 
3) Littrell LA, Wenger DE, Wold LE, et al : Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas : a retrospective review of 174 de novo cases. Radiographics 24 : 1397-1409, 2004
 
4) Knosel T, Werner M, Jung A, et al : Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma? Pathol Res Pract 210 : 194-197, 2014
PubMed
5) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
6) Morrison C, Radmacher M, Mohammed N, et al : MYC amplification and polysomy 8 in chondrosarcoma : array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol 23 : 9369-9376, 2005
PubMed
7) Bovee JV, Cleton-Jansen AM, Rosenberg C, et al : Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189 : 454-462, 1999
PubMed
8) Bridge JA, DeBoer J, Travis J, et al : Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis. Am J Pathol 144 : 215-220, 1994
PubMed
9) Nakashima Y, de Pinieux, Ladanyi M : Mesenchymal chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", IARC Press, Lyon, 2013, pp271-272
 
10) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp193-202
 
11) Frezza AM, Cesari M, Baumhoer D, et al : Mesenchymal chondrosarcoma : prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer 51 : 374-381, 2015
PubMed
12) Fanburg-Smith JC, Auerbach A, Marwaha JS, et al : Reappraisal of mesenchymal chondrosarcoma : novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Hum Pathol 41 : 653-662, 2010
PubMed
13) Wang L, Motoi T, Khanin R, et al : Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51 : 127-139, 2012
PubMed
14) Nakayama R, Miura Y, Ogino J, et al : Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma. Pathol Int 62 : 823-826, 2012
PubMed
15) McCarthy EF, Hogendoorn PCW : Clear cell chondrosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", IARC Press, Lyon, 2013, pp273-274
 
16) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp186-193
 
17) Collins MS, Koyama T, Swee RG, et al : Clear cell chondrosarcoma : radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation. Skeletal Radiol 32 : 687-694, 2003
PubMed
18) Park YK, Cho CH, Chi SG, et al : Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma. Int J Oncol 19 : 749-753, 2001
 
19) Park YK, Park HR, Chi SG, et al : Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma. Int J Oncol 19 : 353-37l, 2001
 
20) Meijer D, de Jong D, Pansuriya TC, et al : Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes Cancer 51 : 899-909, 2012
PubMed
21) Matsuura S, Ishii T, Endo M, et al : Epithelial and cartilaginous differentiation in clear cell chondrosarcoma. Hum Pathol 44 : 237-243, 2013
PubMed
P.56 掲載の参考文献
1) Jaffe HL, Mayer L : An osteoblastic-osteoid tissue forming tumor of a metacarpal bone. Arch Surg 24 : 550-564, 1932
 
2) Jaffe H : "Osteoid osteoma" : a benign osteoblastic tumor composed of osteoid and atypical bone. Arch Surg 31 : 709-728, 1935
 
3) Jaffe HL : Benign osteoblastoma. Bull Hosp Joint Dis 17 : 141-151, 1956
PubMed
4) Lichtenstein L : Benign osteoblastoma : a category of osteoid- and bone-forming tumors other than classical osteoid osteoma, which may be mistaken for giant-cell-tumor or osteogenic sarcoma. Cancer 9 : 1044-1052, 1956
PubMed
5) Dorfman HD : Malignant transformation of benign bone lesions. Proc Natl Cancer Conf 7 : 901-903, 1972
PubMed
6) Wold LE, Pritchard DJ, Wilson DM, et al : Prostaglandin synthesis by osteoid osteoma and osteoblastoma. Mod Pathol 1 : 129-131, 1988
PubMed
7) Mungo DV, Zhang X, Schwarz EM, et al : COX-1 and COX-2 expression in osteoid osteoma. J Orthop Res 20 : 159-162, 2002
PubMed
8) Mirra JM, Kendrick RA, Kendric RE : Pseudomalignant osteoblastoma versus arrested osteosarcoma : a case report. Cancer 37 : 2005-2014, 1976
 
9) Schajowicz F, Lemos C : Malignant osteoblastoma. J Bone Joint Surg Br 58 : 202-211, 1976
PubMed
10) Dorfman HD, Weiss SW : Borderline osteoblastic tumors : problem in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1 : 215-234, 1984
PubMed
11) Lucas DR, Unni KK, Sim FH, et al : Osteoblastoma : clinicopathologic study of 306 cases. Hum Pathol 25 : 117-137, 1994
PubMed
12) Dorfman HD, Czerniak B : Benign osteoblastic tumor. in "Bone Tumors", Mosby, St Louis, 1998, pp85-127
 
P.64 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
3) Jaffe HL : Tumors and Tumorous Conditions of the Bones and Joints, Lea & Febiger, Philadelphia, 1958
 
4) Ackerman LV, Spjut HJ : Atlas of Tumor Pathology, 2nd Series, Fascicle 4, Tumors of Bone and Cartilage, AFIP, Washington DC, 1962
 
5) Spjut HT, Dorfman HD, Fechner RE, et al : Atlas of Tumor Pathology, 2nd Series, Fascicle 5, Tumors of Bone and Cartilage, AFIP, Washington DC, 1971
 
6) Lichtenstein L : Bone Tumors, 5th ed, Mosby, St Louis, 1977
 
7) Dahlin DC, Unni KK : Bone Tumors, General Aspects and Data on 8,542 Cases, 4th ed, Charles C Thomas, Springfield, 1986
 
8) Resnick D : Bone and Joint Imaging, 2nd ed, WB Saunders, Philadelphia, 1996
 
9) Enneking WF : Clinical Musculoskeletal Pathology, Storter Printing, Gainesville, 1970
 
10) 松野丈夫 : 骨腫瘍. 中村利孝他 (編) : 標準整形外科学, 第11版, 医学書院, 2011, pp331-360
 
11) 町並陸生, 牛込新一郎 : 取扱い規約に沿った腫瘍鑑別診断アトラス 骨, 文光堂, 東京, 1992
 
12) Hasegawa T, Shibata T, Hirose T, et al : Osteosarcoma with epithelioid features : an immunohistochemical study. Arch Pathol Lab Med 117 : 295-298,1993
PubMed
13) Bertoni F, Unni KK, McLeod RA, et al : Osteosarcoma resembling osteoblastoma. Cancer 55 : 416-426, 1985
PubMed
14) Dorfman HD, Weiss SW : Borderline osteoblastic tumors : problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1 : 215-234, 1984
PubMed
15) Aycan OE, Vanel D, Righi A, et al : Chondroblastoma-like osteosarcoma : a case report and review. Skeletal Radiol 44 : 869-873, 2015
PubMed
16) Toguchida J, Nakayama T : Molecular genetics of sarcomas : applications to diagnoses and therapy. Cancer Sci 100 : 1573-1580, 2009
PubMed
17) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distingushes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
18) Dujardin F, Binh MB, Bouvier C, et al : MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 24 : 624-637, 2011
PubMed
19) Yoshida A, Ushiku T, Moto T, et al : MDM2 and CDK4 immunohistochemical coexpression in high grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
 
P.75 掲載の参考文献
1) Matsuno T, Unni KK, McLeod RA, et al : Telangiectatic osteogenic sarcoma. Cancer 38 : 2538-2547, 1976
PubMed
2) Oliveira AM, Okada K, Squire J : Telangiectatic osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp289-290
 
3) Matsuno T, Okada K, Knuutila S : Telangiectatic osteosarcoma. in Fletcher CDM, Unni KK, Mertins F (eds) : "WHO Classification of Tumours, Pathology and Genetics Tumours of Soft Tissue and Bone", 3rd ed, IARC Press, Lyon, 2002, pp271-272
 
4) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp82-87
 
5) Martin JW, Squire JA, Zielenska M : The genetics of osteosarcoma. Sarcoma 2012 : 627254, 2012
PubMed
6) Sim FH, Unni KK, Beabout JW, et al : Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg 61A : 207-215, 1979
 
7) Ayala AG, Ro JY, Raymond AK, et al : Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer 64 : 2162-2173, 1989
PubMed
8) Forest M, De Pinieux G, Knuutila S : Secondary osteosarcoma. in Fletcher CDM, Unni KK, Mertins F (eds) : "WHO Classification of Tumours, Pathology and Genetics Tumours of Soft Tissue and Bone", 3rd ed, IARC Press, Lyon, 2002, pp277-278
 
9) Rosenberg AE, Cleton-Jansen AM, de Pinieux G, et al : Conventional osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp282-288
 
10) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp115-117
 
11) Deyrup AT, Montag AG, Inwards CY, et al : Sarcomas arising in Paget disease of bone : a clinicopathologic analysis of 70 cases. Arch Pathol Lab Med 131 : 942-946, 2007
PubMed
12) Unni KK, Dahlin DC, McLeod RA, et al : Intraosseous well-differentiated osteosarcoma. Cancer 40 : 1337-1347, 1977
PubMed
13) Inwards CY, Knuutila S : Low grade central osteosarcoma. in Fletcher CDM, Unni KK, Mertins F (eds) : "WHO Classification of Tumours, Pathology and Genetics Tumours of Soft Tissue and Bone", 3rd ed, IARC Press, Lyon, 2002, pp275-276
 
14) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
15) Yoshida A, Ushiku T, Motoi T, et al : MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
PubMed
16) Inwards CY, Squire J : Low-grade central osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp281-282
 
P.84 掲載の参考文献
1) Lazer A, Mertens F : Parosteal osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp292-293
 
2) Okada K, Frassica FJ, Sim, FH, et al : Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am 76 : 366-378, 1994
PubMed
3) Sheth DS, Yasko AW, Raymond AK, et al : Conventional and dedifferentiate parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer 78 : 2136-2145, 1996
 
4) Hang JF, Chen PC : Parosteal osteosarcoma. Arch Pathol Lab Med 138 : 694-699, 2014
PubMed
5) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
6) Dujardin F, Binh MB, Bouvier C, et al : MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 24 : 624-637, 2011
PubMed
7) Yoshida A, Ushiku T, Motoi T, et al : MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
PubMed
8) Montag AG, Squire J : Perioseal osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp294-295
 
9) Oda Y, Hashimoto H, Tsuneyoshi M, et al : Case report 793. Periosteal osteosarcoma of the clavicle. Skeletal Radiol 22 : 375-377, 1993
PubMed
10) Cesari M, Alberghini M, Vanel D, et al : Periosteal osteosarcoma : a single-institution experience. Cancer 117 : 1731-1735, 2011
PubMed
11) Righi A, Gambarotti M, Benini S, et al : MDM2 and CDK4 expression in periosteal osteosarcoma. Hum Pathol 46 : 549-553, 2015
PubMed
12) Radig K, Schneider-Stock R, Haeckel C, et al : p53 gene mutations in osteosarcomas of low-grade malignancy. Hum Pathol 29 : 1310-1316, 1998
PubMed
13) Wold LE, McCarthy EF, Squire J : High-grade surface osteosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp295-296
 
14) Yamaguchi H, Nojima T, Yagi T, et al : High-grade surface osteosarcoma of the left ilium. A case report and review of the literature. Acta Pathol Jpn 38 : 235-240, 1988
PubMed
15) Staals EL, Bacchini P, Bertoni F : High-grade surface osteosarcoma : a review of 25 cases from the Rizzoli Institute. Cancer 112 : 1592-1599, 2008
PubMed
16) Noble-Topham SE, Burrow SR, Eppert K, et al : SAS is amplified predominantly in surface osteosarcoma. J Orthop Res 14 : 700-705, 1996
PubMed
P.89 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Prees, Lyon, 2013, pp298, 302-304
 
2) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp238-249
 
3) Hauben EI, Jundt G, Cleton-Jansen AM, et al : Desmoplastic fibroma of bone : an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hum Pathol 36 : 1025-1030, 2005
PubMed
P.92 掲載の参考文献
1) Jaffe HL : Giant-cell reparative granuloma, traumatic bone cyst and fibrous (fibro-osseous) dysplasia of the jaw bones. Oral Surg Oral Med Oral Pathol 6 : 159-175, 1953
 
2) Ackerman LV, Spjut HJ : Giant cell reaction in tumors of bone and cartilage. in Spjut HJ, Dorfman HD, Fechner RE, et al (eds) : "Atlas for Tumor Pathology, Section II, Fascicle 4, 1st Series", AFIP, Washington, DC, 1962, p282
 
3) Lorenzo JC, Dorfman HD : Giant cell reparative granuloma of the short tubular bones of the hands and feet. Am J Surg Pathol 4 : 551-563, 1980
PubMed
4) Auclair PL, Cuenin P, Kratochvil FL, et al : A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor. Oral Surg Oral Med Oral Pathol 66 : 197-208, 1988
 
5) Forsyth R, Jundt G : Giant cell lesion of the small bones. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, p320
 
6) Robinson RA, Vincent SD : Central giant cell granuloma. in "AFIP Atlas of Tumor Pathology, Series 4, Fascicle 16, Tumors and Cysts of the Jaws", ARP Press, Silver Spring, 2012, pp183-187
 
7) 仙波伊知郎 : 中心性巨細胞病変. 森永正二郎, 高田隆, 長尾俊孝 (編) : 腫瘍病理鑑別診断アトラス頭頸部腫瘍 II, 文光堂, 2015, pp167-169
 
8) Agaram NP, LeLoarer FV, Zhang L : USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol 45 : 1147-1152, 2014
 
9) Johnson A, Collin A, Rydholm A : Unstable translocation (8 ; 22) in a case of giant cell reparative granuloma. Cancer Genet Cytogenet 177 ; 59-63, 2007
 
10) Struthers PJ, Shear M : Aneurysmal bone cyst of the jaws. Int J Oral Surg 13 : 92-100, 1984
PubMed
P.98 掲載の参考文献
1) Athanasou NA, Bansal M, Forsyth R, et al : Giant cell tumor of bone. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013
 
2) 日本整形外科学会骨軟部腫瘍委員会 (編) : 国立がんセンター全国骨腫瘍登録一覧表, 平成18年度-平成24年度
 
3) Czerniak B : Dorfman and Czerniak's Bone Tumors, 2nd ed, Elsevier Saunders, Philadelphia, 2016, pp692-742
 
4) Fain JS, Unni KK, Beabout JW, et al : Nonepiphyseal giant cell tumor of the long bone. Cancer 71 : 3514-3519, 1993
 
5) Cleven AH, Hocker S, Briaire-de Bruijn l, et al : Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol 39 : 1576-1583, 2015
 
6) 小田義直 : 骨軟部腫瘍の悪性変化とその分子メカニズム. 福岡医学雑誌 102 : 1-7, 2011
 
7) Rock MG, Sim FH, Unni KK, et al : Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Joint Surg Am 68 : 1073-1079, 1986
PubMed
8) Gitelis S, Wang JW, Quast M, et al : Recurrence of giantcell tumor with malignant transformation to a fibrosarcoma twenty-five years after primary treatment. A case report. J Bone Joint Surg Am 71 : 757-761, 1989
 
9) Mori Y, Tsuchiya H, Karita M, et al : Malignant transformation of giant cell tumor 25 years after initial treatment. Clin Orthop Relat Res 381 : 185-191, 2000
PubMed
10) Machinami R, Nishida K, Ishida T, et al : Carcinosarcomatous malignancy, osteosarcoma and squamous cell carcinoma, in giant cell tumor of the right distal femur. Pathol Res Pract 204 : 583-588, 2008
PubMed
P.105 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) 山口岳彦 : 脊索病変の臨床病理. 病理と臨床 27 : 137-145, 2009
Medical*Online
3) 山口岳彦 : 良性脊索細胞腫. 脊椎脊髄ジャーナル 23 : 455-459, 2010
 
4) 山口岳彦 : 脊索病変. 病理と臨床 28 (臨増) : 352-353, 2010
 
5) 山口岳彦 : 良性脊索細胞腫. 青笹克之, 小田義直 (編) : 病理診断プラクティス 骨・軟部腫瘍, 中山書店, 2013, pp366-369
 
6) Yamaguchi T, Suzuki S, Ishiiwa H, et al : Intraosseous benign notochordal cell tumors : overlooked precursors of classic chordomas? Histopathology 44 : 597-602, 2004
PubMed
7) Yamaguchi T, Iwata J, Sugihara S, et al : Distinguishing benign notochordal cell tumor from vertebral chordoma. Skeletal Radiol 37 : 291-299, 2008
PubMed
8) Yamaguchi T, Yamato M, Saotome K : First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion : differential diagnosis of benign and malignant notochordal lesions. Skeletal Radiol 31 : 413-418, 2002
 
9) Deshpande V, Nielsen GP, Rosenthal DI, et al : Intraosseous benign notochord cell tumors (BNCT) : further evidence supporting a relationship to chordoma. Am J Surg Pathol 31 : 1573-1577, 2007
PubMed
10) Larousserie F, Drape JL, Chevrot A, et al : Case 32. International Skeletal Society Members' Meeting 2014
 
11) Ahmed SK, Murata H, Draf W : Clivus chordoma. Is it enough to image the primary site? Skull Base 20 : 111-113, 2010
PubMed
12) Yamaguchi T : On "clivus chordoma : is it enough to image the primary site?" (Skull Base 2010 ; 20 : 111-113). Skull Base 21 : 277-278, 2011
PubMed
13) Vujovic S, Henderson S, Presneau N, et al : Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209 : 157-165, 2006
PubMed
14) Matsubayashi J, Sato E, Nomura M, et al : A case of paravertebral mediastinal chordoma without bone destruction. Skeletal Radiol 41 : 1641-1644, 2012
 
15) Lalam R, Cassar-Pullicino VN, McClure J, et al : Entrapped intralesional marrow : a hitherto undescribed imaging feature of benign notochordal cell tumour. Skeletal Radiol 41 : 725-731, 2012
 
16) Tirabosco R, Mangham DC, Rosenberg AE, et al : Brachyury expression in extra-axial skeletal and soft tissue chordoma : a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 32 : 572-580, 2008
PubMed
17) Kikuchi Y, Yamaguchi T, Kishi H, et al : Pulmonary tumor with notochordal differentiation : report of two cases suggestive of benign notochordal cell tumor of extraosseous origin. Am J Surg Pathol 35 : 1158-1164, 2011
 
18) Takahashi Y, Motoi T, Harada M, et al : Extraosseous benign notochordal cell tumor originating in the lung : a case report. Medicine 94 : e366, 2015
 
P.108 掲載の参考文献
1) Hameed M, Wold LE : Haemangioma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, p332
 
2) 石田剛 : 骨脈管性腫瘍の臨床病理. 病理と臨床 27 : 156-168, 2009
Medical*Online
3) Rosenberg AE, Bovee JVMG : Epithelioid haemangioma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp333-334
 
4) O'Connell JX, Kattapuram SV, Mankin HJ, et al : Epithelioid hemangioma of bone. A tumor often mistaken for lowgrade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol 17 : 610-617, 1993
PubMed
5) Nielsen GP, Srivastava A, Kattapuram S, et al : Epithelioid hemangioma of bone revisited. A study of 50 cases. Am J Surg Pathol 33 : 270-277, 2009
PubMed
6) Evans HL, Raymond AK, Ayala AG : Vascular tumors of bone : a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol 34 : 680-689, 2003
 
P.114 掲載の参考文献
1) Rosenberg AE, Antonescu CR, Bovee JVMG : Epithelioid haemangioendothelioma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IRAC Press, Lyon, 2013
 
2) Weissferdt A, Moran CA : Epithelioid hemangioendothelioma of the bone : a review and update. Adv Anat Pathol 21 : 254-259, 2014
 
3) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid hemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
4) Mendlick MR, Nelson M, Pickering D, et al : Translocation t (1 ; 3) (p36.3 ; q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol 25 : 684-687, 2001
 
5) Honick JL, Fletcher CD : Pseudomyogenic hemangioendothelioma : a distinctive often multicentric tumor with indolent behavior. Am J Surg Pathol 35 : 190-201, 2011
 
6) Walther C, Tayebwa J, Lilljebjorn H, et al : A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol 232 : 534-540, 2014
PubMed
7) Lau K, Massad M, Pollack C, et al : Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement insights from an internet registry in the study of a rare cancer. Chest 140 : 1312-1318, 2011
 
8) Kleer CG, Unni KK, McLeod RA : Epithelioid hemangioendothelioma of bone. Am J Surg Pathol 20 : 1301-1311, 1996
PubMed
9) Bovee JVMG, Rosenberg AE : Angiosarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IRAC Press, Lyon, 2013
 
10) Dunlap JB, Magenis RE, Davis C, et al : Cytogenetic analysis of a primary bone angiosarcoma. Cancer Genet Cytogenet 194 : 1-3, 2009
PubMed
11) Manner J, Radlwimmer B, Hohenberger P, et al : MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 176 : 34-39, 2010
PubMed
12) Verbeke SL, Bertoni F, Bacchini P, et al : Distinct histological features characterize primary angiosarcoma of bone. Histopathology 58 : 254-264, 2011
PubMed
P.117 掲載の参考文献
1) Miu A : Etiological aspects of solitary bone cysts : comments regarding the presence of the disease in two brothers. Is the genetic theory sustainable or is it pure coincidence? -Case report. J Med Life 8 : 509-512, 2015
PubMed
2) Kalil RK : Simple bone cyst. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp350-351
 
3) Aycan OE, Camurcu IY, Ozer D, et al : Unusual localizations of unicameral bone cysts and aneurysmal bone cysts : A retrospective review of 451 cases. Acta Orthop Belg 81 : 209-212, 2015
PubMed
4) Mascard E, Gomez-Brouchet A, Lambot K : Bone cysts : unicameral and aneurysmal bone cyst. Orthop Traumatol Surg Res 101 (1 Suppl) : S119-127, 2015
 
5) Takada J, Hoshi M, Oebisu N, et al : A comparative study of clinicopathological features between simple bone cysts of the calcaneus and the long bone. Foot Ankle Int 35 : 374-382, 2014
 
6) Doganavsargil B, Ayhan E, Argin M, et al : Cystic bone lesions : histopathological spectrum and diagnostic challenges. Turk Patoloji Derg 31 : 95-103, 2015
PubMed
P.121 掲載の参考文献
1) Vigorita VJ : Orthopaedic Pathology, 2nd ed, Lippincott Williams & Wilkins, Philadelphia, 2008, pp319-328
 
2) Ishida T, Dorfman HD : Massive chondroid differentiation in fibrous dysplasia of bone (fibrocartilaginous dysplasia). Am J Surg Pathol 17 : 924-930, 1993
PubMed
3) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp260-274
 
4) DiCaprio MR, Enneking WF : Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 87 : 1848-1864, 2005
PubMed
5) Siegal GP, Bianco P, Dal Cin P : Fibrous dysplasia. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp352-353
 
6) Weinstein LS, Shenker A, Gejman PV, et al : Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325 : 1688-1695, 1991
PubMed
7) Sakamoto A, Oda Y, Iwamoto Y, et al : A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsα mutation at the Arg201 codon : polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn 2 : 67-72, 2000
 
8) Ishida T, Iijima T, Kikuchi F, et al : A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 21 : 493-502, 1992
PubMed
9) Maki M, Saitoh K, Horiuchi H, et al : Comparative study of fibrous dysplasia and osteofibrous dysplasia : histopathological, immunohistochemical, argyrophilic nucleolar organizer region and DNA ploidy analysis. Pathol Int 51 : 603-611, 2001
PubMed
P.124 掲載の参考文献
1) Campanacci M : Osteofibrous dysplasia of long bones as a new clinical entity. Ital J Orthop Traumatol 2 : 221-237, 1976
PubMed
2) Vigorita VJ, Hogendoorn PCW, Sawyer JR : Osteofibrous dysplasia. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp354-355
 
3) Kempson RL : Ossifying fibroma of the long bones. A light and eloctron microscopic study. Arch Pathol 82 : 218-233, 1966
 
4) Unni KK, Inwards CY, Bridge JA, et al (eds) : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joint, AFIP, Washington DC, 2005
 
5) 石田剛 : 骨腫瘍の病理, 文光堂, 2012
 
6) Dorfman HD, Czerniak B : Bone Tumors, Mosby, St Louis, 1998
 
7) Campanacci M, Laus M : Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg Am 63 : 367-375, 1981
PubMed
8) Nakashima Y, Yamamuro T, Fujiwara Y, et al : Osteofibrous dysplasia (ossifying fibroma of long bones). A study of 12 cases. Cancer 52 : 909-914, 1983
 
P.127 掲載の参考文献
1) Jaffe HL : Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 6 : 159-175, 1953
 
2) Lorenzo JC, Dorfman HD : Giant-cell reparative granuloma of short tubular bones of the hands and feet. Am J Surg Pathol 4 : 551-563, 1980
PubMed
3) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
4) Sanerkin NG, Mott MG, Roylance J : An unusual intraosseous lesion with fibroblastic, osteoblastic, aneurysmal and fibromyxoid elements : "solid" variant of aneurysmal bone cyst. Cancer 51 : 2278-2286, 1983
PubMed
5) Oliveira AM, Perez-Atayde AR, Inwards CY, et al : USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165 : 1773-1780, 2004
PubMed
6) Erickson-Johnson MR, Chou MM, Evers BR, et al : Nodular fasciitis : a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest 91 : 1427-1433, 2011
PubMed
P.130 掲載の参考文献
1) Lichtenstein L : Histiocytosis X (eosinophilic granuloma of bone, Letterer-Siwe disease, and Schueller-Christian disease). Further observations of pathological and clinical importance. J Bone Joint Surg Am 46 : 76-90, 1964
PubMed
2) Unni KK, Inwards CY : Langerhans histiocytosis (histiocytosis X, eosinophilic granuloma). in "Dahlin's Bone Tumors", 6th ed, Lippincott Williams & Wilkins, Philadelphia, 2010, pp358-361
 
3) De Young B, Egeler RM, Rollins BJ : Langerhans cell histiocytosis. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp356-357
 
4) Willman CL, Busque L, Griffith BB, et al : Langerhans' -cell histiocytosis (histiocytosis X) -a clonal proliferative disease. N Engl J Med 331 : 154-160, 1994
PubMed
5) Yu RC, Chu C, Buluwela L, et al : Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 343 : 767-768, 1994
PubMed
6) Badalian-Very G, Vergilio JA, Degar BA, et al : Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol 156 : 163-172, 2012
PubMed
7) Brown NA, Furtado LV, Betz BL, et al : High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124 : 1655-1658, 2014
PubMed
P.135 掲載の参考文献
1) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
2) Goldblum JR, Folpe AL, Weiss SW : Enzinger and Weiss's Soft Tissue Tumors, 6th ed, Elsevier Saunders, Philadelphia, 2014
 
3) Vigorita VJ : Orthopaedic Pathology, 2nd ed, Wolters Kluwer, Philadelphia, 2008
 
4) 江原茂 : 骨関節のX線診断, 金原出版, 1995
 
5) Hornick JL : Practical Soft Tissue Pathology : A Diagnostic Approach, Elsevier Saunders, Philadelphia, 2013
 
6) Oda Y, Izumi T, Harimaya K, et al : Pigmented villonodular synovitis with chondroid metaplasia, resembling chondroblastoma of the bone. A report of three cases. Mod Pathol 20 : 545-551, 2007
 
7) Fisher M, Biddinger P, Folpe AL, et al : Chondroid tenosynovial giant cell tumor of the temporal bone. Otol Neurotol 34 : c49-c50, 2013
 
8) Boland JM, Folpe AL, Hornick JL, et al : Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types. Diagnostic and histogenetic implications. Am J Surg Pathol 33 : 1225-1229, 2009
PubMed
9) Grogg KL, Lae ME, Kurtin PJ, et al : Clusterin expression distinguishes follicular dendritic cells tumors from other dendritic cell neoplasms. Report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritis cell tumors. Am J Surg Pathol 28 : 988-998, 2004
 
P.139 掲載の参考文献
1) Sciot R, Bridge JA : Synovial chondromatosis. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, p261
 
2) Nishimura K, Solchaga LA, Caplan AI, et al : Chondroprogenitor cells of synovial tissue. Arthritis Rheum 42 : 2631-2637, 1999
PubMed
3) Davis RI, Hamilton A, Biggart JD : Primary synovial chondromatosis : a clinicopathologic review and assessment of malignant potential. Hum Pathol 29 : 683-688, 1998
PubMed
4) Fetsch JF, Vinh TN, Remotti F, et al : Tenosynovial (extraarticular) chondromatosis : an analysis of 37 cases of an underrecognized clinicopathologic entity with a strong predilection for the hands and feet and a high local recurrence rate. Am J Surg Pathol 27 : 1260-1268, 2003
 
5) Milgram JW : Synovial osteochondromatosis : a histopathological study of thirty cases. J Bone Joint Surg Am 59 : 792-801, 1977
 
6) 石田剛, 今村哲夫 : 非腫瘍性骨関節疾患の病理, 文光堂, 2003, pp54-61
 
7) Buddingh EP, Krallman P, Neff JR, et al : Chromosome 6 abnormalities are recurrent in synovial chondromatosis. Cancer Genet Cytogenet 140 : 18-22, 2003
PubMed
8) Amary MF, Bacsi K, Maggiani F, et al : IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224 : 334-343, 2011
 
9) Damato S, Alorjani M, Bonar F, et al : IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas. Histopathology 60 : 363-365, 2012
 
10) de Sa D, Horner NS, MacDonald A, et al : Arthroscopic surgery for synovial chondromatosis of the hip : a systematic review of rates and predisposing factors for recurrence. Arthroscopy 30 : 1499-1504, 2014
PubMed
11) Sah AP, Geller DS, Mankin HJ, et al : Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case report. J Bone Joint Surg Am 89 : 1321-1328, 2007
PubMed
12) O'Connell JX : Pathology of the synovium. Am J Clin Pathol 114 : 773-784, 2000
 
13) Bertoni F, Unni KK, Beabout JW, et al : Chondrosarcomas of the synovium. Cancer 67 : 155-162, 1991
PubMed
P.142 掲載の参考文献
1) Sanamandra S, Ong KO : Lipoma arborescens. Singapore Med J 55 : 5-11, 2014
PubMed
2) Bejia I, Younes M, Moussa A, et al : Lipoma arborescens affecting multiple joints. Skeletal Radiol 34 : 536-538, 2005
PubMed
3) Natera L, Gelber PE, Erquicia JI, et al : Primary lipoma arborescens of the knee may involve the development of early osteoarthritis if prompt synovectomy is not performed. J Orthopaed Traumatol 16 : 47-53, 2015
PubMed
P.150 掲載の参考文献
1) Antonescu C : Round cell sarcomas beyond Ewing : emerging entities. Histopathology 64 : 26-37, 2014
PubMed
2) Lucke A : Lympho-Sarcom der Achseldrusen ; embolische Geschwulste der Lungen ; allgemeine Leukamie. Tod. Archiv fur pathologische Anatomie und Physiologie und fur klinische Medicin (Virchow's Archiv) 35 : 524-530, 1866
 
3) Machinami R : Small round cell tumours of bone. Virchows Arch A Pathol Anat Histopathol 418 : 475-478, 1991
PubMed
4) Fletcher CDM, Bridge JA, Hogendoorn PCM, et al (eds) : WHO Classification of Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013
 
5) Tanaka M, Yamazaki Y, Kanno Y, et al : Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors. J Clin Invest 124 : 3061-3074, 2014
 
6) DeLaney TF, Hornicek FJ, Lessnick SL, et al : Epidemiology, pathology, and molecular genetics of the Ewing sarcoma family of tumors : Wolters Kluwer ; 2015 [cited (last updated : Dec 16, 2014)]. Available from : http://www.uptodate.com/contents/epidemiology-pathology-andmolecular-genetics-of-the-ewing-sarcoma-family-oftumors.
 
7) 植野映子, 松本誠一, 真鍋淳, 他 : [特徴的な局所進展を示す悪性腫瘍-small round cell tumorの画像診断] 骨軟部. 臨床画像 26 : 15-25, 2010
 
8) Kransdorf MJ, Murphy MD : Imaging of Soft Tissue Tumors, 3rd ed, Lipppincott Williams & Wilkins, Philadelphia, 2014
 
9) Yoshida A, Sekine S, Tsuta K, et al : NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36 : 993-999, 2012
PubMed
10) Bridge RS, Rajaram V, Dehner LP, et al : Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue : a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol 19 : 1-8, 2006
 
P.153 掲載の参考文献
1) Jain D, Jain VK, Vasishta RK, et al : Adamantinoma : a clinicopathological review and update. Diagn Pathol : 3 : 8, 2008
PubMed
2) Bridge JA, Fidler ME, Neff JR, et al : Adamantinoma-like Ewing's sarcoma : genomic confirmation, phenotypic drift. Am J Surg Pathol 23 : 159-165, 1999
 
3) Kikuchi Y, Kishimoto T, Ota S, et al : Adamantinoma-like Ewing family tumor of soft tissue associated with the vagus nerve : a case report and review of literature. Am J Surg Pathol 37 : 772-779, 2013
PubMed
4) 町並陸生 : 骨アダマンチノーマの病理, 特に骨線維性異形成との関連に注目して. 病理と臨床 10 : 1374-1384, 1992
 
5) Unni KK, Inwards CY, Bridge JA, et al : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Bones and Joints, AFIP, Washington DC, 2005 pp299-307
 
6) Gleason BC, Liegl-Atzwanger B, Kozakewich HP, et al : Osteofibrous dysplasia and adamantinoma in children and adolescents : a clinicopathologic reappraisal. Am J Surg Pathol 32 : 363-376, 2008
PubMed
P.158 掲載の参考文献
1) Romeo S, Bovee JVMG, Jundt G : Undifferentiated highgrade pleomorphic sarcoma. in Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : "WHO Classification of Tumours of Soft Tissue and Bone", 4th ed, IARC Press, Lyon, 2013, pp364-365
 
2) Unni KK, Inwards CY : Dahlin's Bone Tumors, 3rd ed, Lippincott Williams & Wilkins, Philadelphia, 2010, pp184-190
 
3) Martignetti JA, Gelb BD, Pierce H, et al : Malignant fibrous histiocytoma : inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22-evidence for a common genetic defect. Genes Chromosomes Cancer 27 : 191-195, 2000
PubMed
4) Tarkkanen M, Larramendy ML, Bohling T, et al : Malignant fibrous histiocytoma of bone : analysis of genomic imbalances by comparative genomic hybridisation and CMYC expression by immunohistochemistry. Eur J Cancer 42 : 1172-1180, 2006
 
5) Horvai AE, Roy R, Borys D, et al : Regulators of skeletal development : a cluster analysis of 206 bone tumors reveals diagnostically useful markers. Mod Pathol 25 : 1452-1461, 2012
PubMed
6) Conner JR, Hornick JL : SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 63 : 36-49, 2013
PubMed
7) Bielack SS, Schroeders A, Fuchs N, et al : Malignant fibrous histiocytoma of bone : a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand 70 : 353-360, 1999
 
8) Campanacci M : Malignant fibrous histiocytoma. in "Bone and Soft Tissue Tumors : Clinical Features, Imaging, Pathology and Treatment", Piccin Nuova Libraria, Padova, 1999, pp161-173
 

第3部 鑑別ポイント

P.168 掲載の参考文献
1) 石田剛 : 骨腫瘍の病理, 文光堂, 2012, pp55-118
 
2) Yoshida A, Ushiku T, Motoi T, et al : Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol 23 : 1279-1288, 2010
PubMed
3) Yalcinkaya U, Doganavsargil B, Sezak M, et al : Clinical and morphological characteristics of osteoid osteoma and osteoblastoma : a retrospective single-center analysis of 204 patients. Ann Diagn Pathol 18 : 319-325, 2014
PubMed
4) Dorfman HD, Weiss SW : Borderline osteoblastic tumors : problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1 : 215-234, 1984
PubMed
5) 石田剛, 今村哲夫 : 非腫瘍性骨関節疾患の病理, 文光堂, 2003, pp177-201
 
6) Spjut HJ, Dorfman HD : Florid reactive periostitis of the tubular bones of the hands and feet. A benign lesion which may simulate osteosarcoma. Am J Surg Pathol 5 : 423-433, 1981
 
7) Tabareau-Delalande F, Collin C, Gomez-Brouchet A, et al : Diagnostic value of investigating GNAS mutations in fibro-osseous lesions : a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod Pathol 26 : 911-921, 2013
PubMed
8) Nora FE, Dahlin DC, Beabout JW : Bizarre parosteal osteochondromatous proliferations of the hands and feet. Am J Surg Pathol 7 : 245-250, 1983
PubMed
9) Nilsson M, Domanski HA, Mertens F, et al : Molecular cytogenetic characterization of recurrent translocation breakpoints in bizarre parosteal osteochondromatous proliferation (Nora's lesion). Hum Pathol 35 : 1063-1069, 2004
 
P.173 掲載の参考文献
1) Kerr DA, Lopez HU, Deshpande V, et al : Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations. Am J Surg Pathol 37 : 787-795, 2013
PubMed
2) Pansuriya TC, van Eijk R, d'Adamo P, et al : Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet 43 : 1256-1261, 2011
 
3) Bianco P, Riminucci M, Majolagbe A, et al : Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15 : 120-128, 2000
PubMed
P.182 掲載の参考文献
1) Monda L, Wick MR : S-100 protein immunostaining in the differential diagnosis of chondroblastoma. Hum Pathol 16 : 287-293, 1985
PubMed
2) Behjati S, Tarpey PS, Presneau N, et al : Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45 : 1479-1482, 2013
PubMed
3) Presneau N, Baumhoer D, Behjati S, et al : Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res 1 : 113-123, 2015
PubMed
4) Cleven AH, Hocker S, Briaire-de Bruijn I, et al : Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol 39 : 1576-1583, 2015
PubMed
5) Oliveira AM, Hsi BL, Weremowicz S, et al : USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 64 : 1920-1923, 2004
PubMed
6) Oliveira AM, Perez-Atayde AR, Inwards CY, et al : USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165 : 1773-1780, 2004
PubMed
7) Agaram NP, LeLoarer FV, Zhang L, et al : USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol 45 : 1147-1152, 2014
 
8) Wang CS, Yin QH, Liao JS, et al : Giant cell-rich osteosarcoma in long bones : clinical, radiological and pathological features. Radiol Med 118 : 1324-1334, 2013
PubMed
9) Nagata S, Nishimura H, Uchida M, et al : Giant cell-rich osteosarcoma of the distal femur : radiographic and magnetic resonance imaging findings. Radiat Med 24 : 228-232, 2006
PubMed
10) Chow LT : Fibular giant cell-rich osteosarcoma virtually indistinguishable radiographically and histopathologically from giant cell tumor-analysis of subtle differentiating features. APMIS 123 : 530-539, 2015
PubMed
P.191 掲載の参考文献
1) Shibuya R, Matsuyama A, Nakamoto M, et al : The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 : 599-605, 2014
 
2) Yoshida A, Sekine S, Tsuta K, et al : NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36 : 993-999, 2012
PubMed
3) Specht K, Sung YS, Zhang L, et al : Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas : further evidence toward distinct pathologic entities. Genes Chromosomes Cancer 53 : 622-633, 2014
PubMed
4) Sugita S, Arai Y, Tonooka A, et al : A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma : a genetically distinct variant of Ewing-like sarcoma. Am J Surg Pathol 38 : 1571-1576, 2014
PubMed
5) Yoshida A, Goto K, Kodaira M, et al : CIC-rearranged sarcomas : a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol 40 : 313-323, 2016
PubMed
6) Kawamura-Saito M, Yamazaki Y, Kaneko K, et al : Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t (4 ; 19) (q35 ; q13) translocation. Hum Mol Genet 15 : 2125-2137, 2006
 
7) Peters TL, Kumar V, Polikepahad S, et al : BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol 28 : 575-586, 2015
PubMed
8) Pierron G, Tirode F, Lucchesi C, et al : A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 44 : 461-466, 2012
 
9) Puls F, Niblett A, Marland G, et al : BCOR-CCNB3 (Ewing-like) sarcoma : a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Am J Surg Pathol 38 : 1307-1318, 2014
PubMed
10) Shibayama T, Okamoto T, Nakashima Y, et al : Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3 : a clinicopathological report of three pediatric cases. Pathol Int 65 : 410-414, 2015
PubMed
11) Nakajima H, Sim FH, Bond JR, et al : Small cell osteosarcoma of bone. Review of 72 cases. Cancer 79 : 2095-2106, 1997
PubMed
12) Righi A, Gambarotti M, Longo S, et al : Small cell osteosarcoma : clinicopathologic, immunohistochemical, and molecular analysis of 36 cases. Am J Surg Pathol 39 : 691-699, 2015
PubMed
13) Sim FH, Unni KK, Beabout JW, et al : Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg Am 61 : 207-215, 1979
 
14) Machado I, Alberghini M, Giner F, et al : Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases. Histopathology 57 : 162-167, 2010
PubMed
15) Debelenko LV, McGregor LM, Shivakumar BR, et al : A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma. Genes Chromosomes Cancer 50 : 1054-1062, 2011
 
16) Wojcik JB, Bellizzi AM, Dal Cin P, et al : Primary sclerosing epithelioid fibrosarcoma of bone : analysis of a series. Am J Surg Pathol 38 : 1538-1544, 2014
PubMed
17) Maruyama D, Watanabe T, Beppu Y, et al : Primary bone lymphoma : a new and detailed characterization of 28 patients in a single-institution study. Jpn J Clin Oncol 37 : 216-223, 2007
 
18) Nagasaka T, Nakamura S, Medeiros LJ, et al : Anaplastic large cell lymphomas presented as bone lesions : a clinicopathologic study of six cases and review of the literature. Mod Pathol 13 : 1143-1149, 2000
PubMed
19) Ozdemirli M, Fanburg-Smith JC, Hartmann DP, et al : Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma : a report of four cases and review of the literature. Am J Surg Pathol 22 : 795-804, 1998
 
20) Lin O, Filippa DA, Teruya-Feldstein J : Immunohistochemical evaluation of FLI-1 in acute lymphoblastic lymphoma (ALL) : a potential diagnostic pitfall. Appl Immunohistochem Mol Morphol 17 : 409-412, 2009
PubMed
21) Meis JM, Butler JJ, Osborne BM, et al : Granulocytic sarcoma in nonleukemic patients. Cancer 58 : 2697-2709, 1986
PubMed
22) Nakashima Y, Unni KK, Shives TC, et al : Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 57 : 2444-2453, 1986
PubMed
23) Wehrli BM, Huang W, De Crombrugghe B, et al : Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 34 : 263-269, 2003
PubMed
24) Wang L, Motoi T, Khanin R, et al : Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 51 : 127-139, 2012
PubMed
25) Bishop JA, Alaggio R, Zhang L, et al : Adamantinoma-like Ewing family tumors of the head and neck : a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol 39 : 1267-1274, 2015
PubMed
P.198 掲載の参考文献
1) Kurzawa P, Kattapuram S, Hornicek FJ, et al : Primary myoepithelioma of bone : a report of 8 cases. Am J Surg Pathol 37 : 960-968, 2013
 
2) Vujovic S, Henderson S, Presneau N, et al : Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209 : 157-165, 2006
PubMed
3) Miettinen M, Wang Z, Lasota J, et al : Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas : an immunohistochemical study of 5229 cases. Am J Surg Pathol 39 : 1305-1312, 2015
PubMed
4) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
5) Doyle LA, Fletcher CD, Hornick JL : Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. Am J Surg Pathol 40 : 94-102, 2016
PubMed
6) Yoshida A, Sekine S, Tsuta K, et al : NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36 : 993-999, 2012
PubMed
7) Shibuya R, Matsuyama A, Nakamoto M, et al : The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 : 599-605, 2014
 

第4部 臨床との連携

P.203 掲載の参考文献
1) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015, pp42-51
 
2) 竹山信成, 桧垣昇三, 三輪隆他 : 膝周辺の骨巨細胞腫の治療-準切除術について. 臨床整形外科 20 : 851-857, 1985
 
3) Malawer MM, Bickels J, Meller I, et al : Cryosurgery in the treatment of giant cell tumor. A long-term follow up study. Clin Orthop Relat Res 359 : 176-188, 1999
PubMed
4) Kawaguchi N, Matumoto S, Manabe J : New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma : analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 121 : 555-563, 1995
 
5) Weber MA, Sprengel SD, Omlor GW, et al : Clinical longterm outcome, technical success, and cost analysis of radiofrequency ablation for the treatment of osteoblastomas and spinal osteoid osteomas in comparison to open surgical resection. Skeletal Radiol 44 : 981-993, 2015
 
6) Gaston CL, Bhumbra R, Watanuki M, et al : Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br 93 : 1665-1669, 2011
 
7) Manabe J, Ahmed AR, Kawaguchi N, et al : Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419 : 258-266, 2004
 
8) Sugiura H, Takahashi M, Nakanishi K, et al : Pasteurized intercalary autogenous bone graft combined with vascularized fibula. Clin Orthop Relat Res 456 : 196-202, 2007
PubMed
P.208 掲載の参考文献
1) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015, pp35, 36, 60
 
2) Iwamoto Y, Tanaka K, Isu K, et al : Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan : NECO-93J and NECO-95J. J Orthop Sci 14 : 397-404, 2009
PubMed
3) Iwamoto Y, Tanaka K : The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group. Jpn J Clin Oncol 42 : 467-470, 2012
 
4) Womer RB, West DC, Krailo MD, et al : Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma : a report from the Children's Oncology Group. J Clin Oncol 30 : 4148-4154, 2012
 
5) Kawaguchi S, Sun T, Lin PP, et al : Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma? Clin Orthop Relat Res 472 : 983-989, 2014
PubMed
6) Italiano A, Mir O, Cioffi A, et al : Advanced chondrosarcomas : role of chemotherapy and survival. Ann Oncol 24 : 2916-2922, 2013
PubMed
7) Dickey ID, Rose PS, Fuchs B, et al : Dedifferentiated chondrosarcoma : the role of chemotherapy with updated outcomes. J Bone Joint Surg Am 86-A : 2412-2418, 2004
PubMed
8) Cesari M, Bertoni F, Bacchini P, et al : Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori 93 : 423-427, 2007
 
9) Imai R, Kamada T, Sugahara S, et al : Carbon ion radiotherapy for sacral chordoma. Br J Radiol 84 : S48-54, 2011
PubMed
P.213 掲載の参考文献
1) Puls F, Niblett AJ, Mangham DC : Molecular pathology of bone tumours : diagnostic implications. Histopathology 64 : 461-476, 2014
PubMed
2) Horvai AE, Roy R, Borys D, et al : Regulators of skeletal development : a cluster analysis of 206 bone tumors reveals diagnostically useful markers. Mod Pathol 25 : 1452-1461, 2012
PubMed
3) Conner JR, Hornick JL : SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 63 : 36-49, 2013
PubMed
4) Hosono A, Yamaguchi U, Makimoto A, et al : Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. J Clin Pathol 60 : 410-414, 2007
PubMed
5) Wan Y, Zhao W, Jiang Y, et al : β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma. Hum Pathol 45 : 1459-1465, 2014
 
6) Yoshida A, Ushiku T, Motoi T, et al : MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma : correlation with a dedifferentiated subtype. Am J Surg Pathol 36 : 423-431, 2012
PubMed
7) Konishi E, Nakashima Y, Iwasa Y, et al : Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol 41 : 208-213, 2010
PubMed
8) Szuhai K, Cleton-Jansen A-M, Hogendoorn PCW, et al : Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 205 : 193-204, 2012
 
9) Shibuya R, Matsuyama A, Nakamoto M, et al : The combination of CD99 and NKX2.2, a transcription target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 : 599-605, 2014
 
10) Peters TL, Kumar V, Polikepahad S, et al : BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol 28 : 575-586, 2015
PubMed
11) Behjati S, Tarpey PS, Presneau N, et al : Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45 : 1479-1482, 2014
 
12) Oliveira AM, Chou MM : USP6-induced neoplasms : the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 45 : 1-11, 2014
PubMed
13) Roden AC, Hu X, Kip S, et al : BRAF V600E expression in Langerhans cell histiocytosis. Clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38 : 548-551, 2014
PubMed
14) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid hemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
15) Antonescu CR, Le Loarer F, Mosquera JM, et al : Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 52 : 775-784, 2013
PubMed
16) Athanasou NA, Quinn J, Heryet A, et al : Effect of decalcification agents on immunoreactivity of cellular antigens. J Clin Pathol 40 : 874-878, 1987
PubMed
17) Bussolati G, Leonardo E : Technical pitfalls potentially affecting diagnoses in immunohistochemistry. J Clin Pathol 61 : 1184-1192, 2008
PubMed
P.220 掲載の参考文献
1) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
2) 落合淳志 : 癌の治療効果と病理組織診断, 各種治療後の病理組織診断 (総論). 病理と臨床 26 : 440-446, 2008
 
3) Ayala AG, Raymond AK, Jaffe R : The pathologist's role in the diagnosis and treatment of osteosarcoma in children. Hum Pathol 15 : 258-266, 1984
 
4) Picci P, Bacci G, Campanaci M, et al : Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viab1e and non-viab1e tumor. Cancer 56 : 1515-1521, 1985
 
5) 平賀博明 : 骨肉腫に対する化学療法の最前線. 整形外科 61 : 809-814, 2010
 
6) 蛭田啓之, 町並陸生, 神田浩明, 他 : 骨肉腫の術前化学療法組織学的効果判断と問題点. 日本整形外科学会雑誌 84 : 1120-1125, 2010
 
7) 日本整形外科学会 骨・軟部腫瘍委員会 (編) : 骨・軟部肉腫切除縁評価法, 金原出版, 1989
 
8) Kawaguchi N, Matumoto S, Manabe J : New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 121 : 555-563, 1995
 
9) Kawaguchi N, Ahmed AR, Matsumoto S, et al : The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop 419 : 165-172, 2004
 
10) 阿江啓介, 松本誠一, 下地尚, 他 : 切除縁評価法の改正にむけて-バリア概念の検証. 日本整形外科学会雑誌 86 : 567-574, 2014
 
11) 阿江啓介, 松本誠一 : 肉腫外科治療の最前線 : 切除縁-ユニークな切除縁評価法と, 根拠に基づく安全な手術計画. 医学のあゆみ 254 : 285-290, 2015
Medical*Online
P.224 掲載の参考文献
1) 三上芳喜 : 病理組織・細胞診断報告書の読み方. 笹野公伸, 森谷卓也, 真鍋俊明 (編) : 臨床医・初期研究医のための病理検査室利用ガイド, 文光堂, 2004, pp83-111
 
2) 日本整形外科学会・日本病理学会 (編) : 悪性骨腫瘍取扱い規約, 第4版, 金原出版, 2015
 
3) Laster S : Soft-tissue tumors (sarcomas). in "Manual of Surgical Pathology", Churchill Livingstone, Philadelphia, 2001, pp116-128
 
4) Rubin BP, Antonescu CR, Gannon FH, et al : Protocol for the examination of specimens from patients with tumors of bone. Arch Pathol Lab Med 134 : e1-e7, 2010
PubMed
5) Fletcher CDM, Bridge JA, Hogendoorn PCW, et al (eds) : World Health Organization Classification of Tumours, Pathology & Genetics, Tumours of Soft Tissue and Bone, 4th ed, IARC Press, Lyon, 2013, pp246-247
 
6) Fleming ID, Cooper JS, Henson DE, et al (eds) : American Joint Committee on Cancer, Manual for Staging of Cancer, 5th ed, JB Lippincott, Philadelphia, 1997
 

書評

最近チェックした商品履歴

Loading...